Journey Strategic Wealth’s CME Group CME Stock Holding History

Journey Strategic Wealth’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.31M	Buy	4,430 +598	+16%	+$178K	0.03%	150
2025 Q4	$1.05M	Buy	3,832 +887	+30%	+$241K	0.03%	168
2025 Q3	$796K	Sell	2,945 -924	-24%	-$251K	0.02%	204
2025 Q2	$1.07M	Buy	3,869 +2,034	+111%	+$553K	0.03%	158
2025 Q1	$487K	Sell	1,835 -67	-4%	-$16.5K	0.02%	232
2024 Q4	$442K	Buy	1,902 +489	+35%	+$112K	0.02%	244
2024 Q3	$312K	Buy	1,413 +317	+29%	+$65.6K	0.01%	324
2024 Q2	$216K	Buy	+1,096	New	+$226K	0.01%	347
2023 Q2	–	Sell	-1,210	Closed	-$232K	–	217
2023 Q1	$232K	Buy	+1,210	New	+$219K	0.02%	201

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Journey Strategic Wealth's CME Position: Q1 2026 in Review

Journey Strategic Wealth increased its CME Group (CME) stake by 16% in Q1 2026, buying an estimated $178K and bringing the position to 4,430 shares worth $1.31M. The position accounts for 0.03% of the portfolio, ranked #150.

Journey Strategic Wealth first reported a position in CME in Q1 2023 and has held it in 9 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Journey Strategic Wealth held 4,430 shares of CME Group worth $1.31M as of Q1 2026.
Journey Strategic Wealth bought 598 CME Group shares in Q1 2026, an estimated $178K.
CME Group made up 0.03% of Journey Strategic Wealth's portfolio in Q1 2026, its #150 holding.
Journey Strategic Wealth first reported a position in CME Group in Q1 2023 and has held it in 9 quarters since.
1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Journey Strategic Wealth's 13F filing for Q1 2026, filed 15 Apr 2026.